Older Patients with Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) Have Higher Rates of Lean MASLD and More Advanced Fibrosis but Better Health Related Quality of Life (HRQL)
Zobair M Younossi, MD, MPH, FAASLD
, Abstract Presenter
Global
MASLD
Public Health
Objectives
Analyze structural and social determinants of health that affect disparities in MASLD outcomes.
Review strategies to promote equity in MASLD care
Analyze structural and social determinants of health that affect disparities in MASLD management.